Seasonal Flu
|
Pandemic Flu
|
Outbreaks follow predictable seasonal patterns; occurs annually, usually in winter, in temperate climates
|
Occurs rarely (three times in 20th century - last in 1968)
|
Usually some immunity built up from previous exposure
|
No previous exposure; little or no pre-existing immunity
|
Healthy adults usually not at risk for serious complications; the very young, the elderly and those with certain underlying health conditions at increased risk for serious complications
|
Healthy people may be at increased risk for serious complications
|
Health systems can usually meet public and patient needs
|
Health systems may be overwhelmed
|
Vaccine developed based on known flu strains and available for annual flu season
|
Vaccine probably would not be available in the early stages of a pandemic
|
Adequate supplies of antivirals are usually available
|
Effective antivirals may be in limited supply
|
Average U.S. deaths approximately 36,000/yr
|
Number of deaths could be quite high (e.g., U.S. 1918 death toll approximately 675,000)
|
Symptoms: fever, cough, runny nose, muscle pain. Deaths often caused by complications, such as pneumonia.
|
Symptoms may be more severe and complications more frequent
|
Generally causes modest impact on society (e.g., some school closing, encouragement of people who are sick to stay home)
|
May cause major impact on society (e.g. widespread restrictions on travel, closings of schools and businesses, cancellation of large public gatherings)
|
Manageable impact on domestic and world economy
|
Potential for severe impact on domestic and world economy
|